Literature DB >> 1978271

Neurochemical basis of neurotoxicity.

J W Gibb1, M Johnson, G R Hanson.   

Abstract

The neurotoxic properties of 6-hydroxydopamine and 5,7-dihydroxytryptamine are reviewed. The neurochemical responses of the dopaminergic and serotonergic systems after methamphetamine (METH) are reported. METH decreased activities of tyrosine hydroxylase and tryptophan hydroxylase; concentrations of dopamine (DA) and 5-hydroxytryptamine (5HT) and their respective metabolites were decreased in parallel with the decline in activity of the enzymes. When a variety of pharmacologic or surgical procedures were used to decrease DA content prior to administration of METH, the effects of METH were attenuated. From these data it is inferred that DA is essential for the METH-induced response. 3,4-Methylenedioxymethamphetamine (MDMA) produced similar effects which were also DA-dependent. Evidence for a role of glutamate and oxidative stress in the neurotoxicity of the amphetamines is presented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978271

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  19 in total

1.  The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.

Authors:  David M Thomas; Mariana Angoa Pérez; Dina M Francescutti-Verbeem; Mrudang M Shah; Donald M Kuhn
Journal:  J Neurochem       Date:  2010-09-06       Impact factor: 5.372

Review 2.  MDMA use and neurocognition: a meta-analytic review.

Authors:  Ari D Kalechstein; Richard De La Garza; James J Mahoney; William E Fantegrossi; Thomas F Newton
Journal:  Psychopharmacology (Berl)       Date:  2006-11-03       Impact factor: 4.530

Review 3.  Causes and consequences of methamphetamine and MDMA toxicity.

Authors:  Maria S Quinton; Bryan K Yamamoto
Journal:  AAPS J       Date:  2006-05-12       Impact factor: 4.009

4.  Positive and negative feedback learning and associated dopamine and serotonin transporter binding after methamphetamine.

Authors:  Alexandra Stolyarova; Steve J O'Dell; John F Marshall; Alicia Izquierdo
Journal:  Behav Brain Res       Date:  2014-06-21       Impact factor: 3.332

Review 5.  Nucleus accumbens invulnerability to methamphetamine neurotoxicity.

Authors:  Donald M Kuhn; Mariana Angoa-Pérez; David M Thomas
Journal:  ILAR J       Date:  2011

6.  Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.

Authors:  D S Reynolds; R J Carter; A J Morton
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

7.  DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).

Authors:  F Fornai; P Lenzi; G Frenzilli; M Gesi; M Ferrucci; G Lazzeri; F Biagioni; M Nigro; A Falleni; M Giusiani; A Pellegrini; F Blandini; S Ruggieri; A Paparelli
Journal:  Psychopharmacology (Berl)       Date:  2003-12-13       Impact factor: 4.530

Review 8.  The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Authors:  Bryan K Yamamoto; Jamie Raudensky
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-15       Impact factor: 4.147

9.  Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone.

Authors:  B N Johnson; B K Yamamoto
Journal:  Neuroscience       Date:  2009-02-03       Impact factor: 3.590

Review 10.  Advances in the molecular characterization of tryptophan hydroxylase.

Authors:  S M Mockus; K E Vrana
Journal:  J Mol Neurosci       Date:  1998-06       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.